Delivery Order SPE2DB20D1100-SPE2DB25FC2Z8

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,028,451 units of the pharmaceutical product dactinomycin 500 mcg vials. The $3,570.00 contract has a performance period ending on March 21, 2024. AmerisourceBergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor for this delivery order. The award is not associated with a set-aside...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 mcg vials of the drug dactinomycin. The contract has a ceiling value of $10,200.00 and a period of performance through November 4, 2024. The contract is a firm-fixed-price type and was not set aside for any specific business category. AmerisourceBergen, a for-profit organization, is providing these pharmaceutical products to support...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
The U.S. government's Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at $5,193.87. The contract is to provide a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,046.54 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which does not have a set-aside designation, covers the supply of a comprehensive range of medical products including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits to support military healthcare programs globally. This delivery order is part of a larger...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of various pharmaceutical products and medical supplies. The $1,855.80 Firm Fixed Price contract has an ultimate completion date of July 24, 2024 and is not designated as a set-aside. This Delivery Order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,443.49 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of a variety of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,154.86, is for the delivery of various pharmaceutical products and medical supplies to support federal healthcare programs, particularly military and veterans' healthcare systems. The contract is a firm fixed price delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,564.63 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of pharmaceutical and medical products. This contract is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. The contract encompasses a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of a range of medical products and pharmaceuticals. The contract has a ceiling value of $10,750.82 and a performance period extending through May 6, 2025. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at $999,999,999.00 and in effect through...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC2Z8
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,942.61 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,235,008 vials of the drug Dactinomycin 500 mcg. The contract has a period of performance ending on May 14, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to various government agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/12/25, 12:17 PM